Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01833247 · ClinicalTrials.gov registry record
Lactic Acidosis During and After Seizures
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 12
- Enrollment target
NCT01833247: Completed study, sponsored by Stanford University.
NCT01833247 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01833247 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This project looks at the time course of lactic acid rise (if any) after seizures. Salivary and capillary lactic acid are tested. This type of measurement may be useful in signalling the occurrence or recent history of a seizure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01833247
The ClinicalTrials.gov registry entry for NCT01833247 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01833247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01833247 about?
NCT01833247 is a clinical study titled "Lactic Acidosis During and After Seizures". This project looks at the time course of lactic acid rise (if any) after seizures. Salivary and capillary lactic acid are tested. This type of measurement may be useful in signalling the occurrence or recent history of a seizure.
What is the current status of trial NCT01833247?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2012-07. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01833247?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.